The primary objective of this study is to compare the medication adherence measured by PDC of patients with FDC or double-pill combination therapy in real-world Japanese therapeutic practice.The further objective of this study is how much influence the background of patients to the adherence.
Study Type
OBSERVATIONAL
subjects treated with telmisartan/hydrochlorothiazide
Subjects treated with Telmisartan and amlodipine
subjects treated with Telmisartan+hydrochlorothiazide double-pill combination group
Nippon Boehringer Ingelheim Co., Ltd.
Tokyo, Japan
Proportion of days covered of patients treated with single- and double- combination therapy
Time frame: 180 days
Demographic and clinical characteristics of patients treated with single- and double combination
Time frame: 180 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
subjects treated with telmisartan+amlodipine double pill